The 2025 Cardinal Health Advanced Therapies Report features the cancer journey of Conner Strong & Buckelew’s Bradley (Brad) Watts. Diagnosed with follicular lymphoma and diffuse large B-cell non-Hodgkin’s lymphoma at 29, Brad underwent various treatments, including chemotherapy, radiation, stem cell transplant, immunotherapy, and ultimately CAR T-cell therapy. The report chronicles Brad’s inspiring story and highlights the importance of a strong support system and advocacy. It also addresses key advanced therapy challenges including transportation and logistics, long treatment lead times and life after treatment.

Brad Watts
Vice President, Business Development Executive

Driven by his personal cancer journey, Brad has become a passionate Patient Advocate who understands that delays in clinical trials, unexpected losses and unforeseen coverage gaps can have a devastating impact on patients who need lifesaving therapies and don’t have time to wait. He has dedicated his professional life as Vice President, Business Development Executive at Conner Strong & Buckelew to supporting the life sciences field — helping organizations find insurance and integrated risk solutions that enable them to stay focused on developing and testing new treatments and getting life changing therapies to physicians and patients as quickly as possible. 

Today,  in addition to his patient advocacy and life sciences work, Brad is flourishing and thoroughly enjoying life as a husband and father. Read the full report on the Cardinal Health website.